Sellas Life Sciences Group Inc (SLS)
Operating Cash Flow Growth
-3.52%
Quarterly · Period ending:
SLS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-3.52%period ending
Latest reported-3.52%period ending
SLS Quarterly Cash from Operations YoY % (-666.43% → -3.52%)
Year-over-year change
High-resolution chart · PNG
SLS operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -3.5198% | |
| 2.4697% | |
| 31.2037% | |
| 9.4543% | |
| 24.2925% | |
| 15.7142% | |
| -48.2487% | |
| -13.2618% | |
| -27.9672% | |
| 11.2641% | |
| 6.347% | |
| -19.9443% | |
| -31.3314% | |
| -69.6084% | |
| -3.537% | |
| 2.2457% | |
| -17.6194% | |
| 30.373% | |
| -245.3271% | |
| -61.973% | |
| -44.8684% | |
| -50.3294% | |
| 181.9923% | |
| 5% | |
| 27.384% | |
| -36.8664% | |
| 8.3205% | |
| 73.0321% | |
| 26.0835% | |
| 7.6254% | |
| -129.8708% | |
| -125.773% | |
| 34.1109% | |
| 48.0681% | |
| 290.6125% | |
| 48.6075% | |
| 16.8045% | |
| 21.2772% | |
| 47.6577% | |
| -29.035% | |
| 3.1031% | |
| -14.3648% | |
| -42.2694% | |
| 14.8118% | |
| 8.58% | |
| -43.5885% | |
| -26.8209% | |
| -39.1206% | |
| -82.1143% | |
| -50.966% | |
| -63.9125% | |
| -91.6687% | |
| -5.6042% | |
| -9.13% | |
| -23.9626% | |
| -22.0334% | |
| -66.1739% | |
| -61.3809% | |
| -123.0605% | |
| -52.5704% | |
| -9.4955% | |
| -23.8543% | |
| 43.1569% | |
| 26.5112% | |
| -34.0687% | |
| 8.5329% | |
| -20.2194% | |
| -29.0377% | |
| -3.6745% | |
| -60.1918% | |
| -24.7719% | |
| -10.1307% | |
| -310.9399% | |
| -56.7669% | |
| -666.4336% |